Thanks for the comments and I concur...and will add this...Elite has never been this well positioned as a business. If we see new submissions and approvals. sales in Israel (and expansion beyond that with the very capable Dexcel), and Kirkov delivering on his mission, Elite investors can just sit and watch, the business results will not merely continue to roll in (revenues and profits), but the velocity of the growth will be excellent and the target of $100 million in annual revenues a sooner than later reality.